ANGIOGENESIS ASSESSMENT IN BASAL CELL CARCINOMA

Authors

  • A ALEDAVOOD
  • F SARI ASLANI From the Department of Pathology, Shiraz University of Medical Sciences, Shiraz, I.R. Iran.
Abstract:

Basal cell carcinoma (BCC) is currently the most common cutaneous cancer found in humans. Although it generally shows a relatively benign course (BCCl), some cases show aggressive behavior (BCC2). Until recently, traditional histologic diagnostic criteria have failed to discriminate unequivocally between BCC 1 and BCC2. In this study we selected 50 cases of BCC and categorized them into two groups (BCCl and BCC2) on the basis of histologic criteria and then examined the rate of angiogenesis to establish if it correlates with their histological features and/or clinical behavior. The vessels were highlighted by immunohistochemical staining for factor VIII-related antigen in formalin fixed paraffin embedded tissues. All 25 cases of BCC2, whose clinical behavior was aggressive had microvessel counts significantly higher than that of the BCC I group with mean values of 50.24 and 20.9 for BCC2 and BCCl respectively. But there were eight cases of morphological BCCI who had aggressive clinical behavior and interestingly had microvessel counts higher than the other cases of BCC 1. The findings of the present study seem to establish a correlation between tumor angiogenesis and clinicobiologicaI parameters of aggressiveness. From this point of view the assay of microvessel density might be helpful in selecting patients with BCCs at high risk for recurrence or metastasis, who could benefit from additional therapies and closer followup.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

angiogenesis assessment in basal cell carcinoma

basal cell carcinoma (bcc) is currently the most common cutaneous cancer found in humans. although it generally shows a relatively benign course (bccl), some cases show aggressive behavior (bcc2). until recently, traditional histologic diagnostic criteria have failed to discriminate unequivocally between bcc 1 and bcc2. in this study we selected 50 cases of bcc and categorized them into two gro...

full text

Comparison of COX2 expression in radiation induced basal cell carcinoma and non-radiation induced basal cell carcinoma

Background: Radiation-induced basal cell carcinoma (BCC) can be multiple, large, and recurring, which complicates its treatment in some cases. According to reports on the role of cyclooxygenase 2 (COX2) inhibitors in the treatment or prevention of non-melanoma skin cancers and considering the fact that COX2 expression has not been evaluated in radiation-in...

full text

Basal cell carcinoma of the lower extremities

Background: Basal cell carcinoma (BCC), the most common form of skin cancer, usually occurs in the sun-exposed areas of the body like head and neck, yet is also seen in unexpected sites. Myriad studies have mentioned a lower limb BCC incidence rate of 1.5-13.5%.Methods: The present retrospective cross-sectional study was conducted on 650 BCC patients, who were referred to the dermatology tumor ...

full text

The Usefulness of CD10 in Distinguishing between Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma

Background & Objectives:  CD10 is a cell surface enzyme with metalloendopeptidase activity, also known as Common Acute Lymphoblastic Leukaemia Antigen, which mainly serves as a marker for acute lymphoblastic leukemia (ALL). To date and to the best of our knowledge, only few comparative immunohistochemical studies have assessed CD10 expression in cutaneous epithelial neoplasms. Our goal was to d...

full text

immunohistochemistry assessment of p53 protein in basal cell carcinoma

the most frequently mutated tumor suppressor gene found in human cancer is p53. in a normal situation, p53 is activated upon the induction of dna damage to either arrest the cell cycle or else induce apoptosis. however, when mutated, p53 is no longer able to properly accomplish these functions. our aim was to investigate p53 protein alteration in cases of basal cell carcinoma (bcc) and compare ...

full text

Basal cell carcinoma in a young woman: A case report

Basal cell carcinoma (BCC) is a malignant tumor of epithelial cells that is composed of cells similar to those in the basal area of the epidermis and its appendages. Ninety- five percent of individuals with BCC are between 40 and 79 years old. It rarely occurs in younger individuals. Herein, a 20- year- old woman with type III skin, who had a BCC on her chin is presented. Since the clinic...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 15  issue 2

pages  73- 77

publication date 2001-08

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023